Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

The rise of AI reveals the differences between human and machine learning, sparking new insights into the human brain.

Researchers at FORTH have developed a new type of artificial neural network (ANN) that incorporates features of biological ...

"I think we think of AI as primarily a bunch of the software geeks who are out there coding somewhere, but there's real ...

Neither the public or the tech giants pushing artificial intelligence understand its long-term implications, warns former ...

As artificial intelligence becomes increasingly integrated into higher education, questions arise about its role in fostering ...

NEW HAVEN, Conn. - BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company focused on artificial ...

In a recent conversation with Peter Gloor at MIT, we talk about swarm creativity, COINs, AI and a collective human-AI future.

Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with ...

Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...